Abstract

BackgroundThe purpose of this study was to evaluate the effectiveness of a patient education program developed to facilitate statin adherence.MethodsA controlled trial was designed to test the effectiveness of a multifaceted patient education program to facilitate statin adherence. The program included a brief, in-office physician counseling kit followed by patient mailings. The primary end point was adherence to filling statin prescriptions during a 120-day period. Patients new to statins enrolled and completed a survey. Data from a national pharmacy claims database were used to track adherence.ResultsPatients new to statin therapy exposed to a patient counseling and education program achieved a 12.4 higher average number of statin prescription fill days and were 10% more likely to fill prescriptions for at least 120 days (p = .01).ConclusionBrief in-office counseling on cardiovascular risk followed by patient education mailings can be effective in increasing adherence. Physicians found a one-minute counseling tool and pocket guidelines useful in counseling patients.

Highlights

  • The purpose of this study was to evaluate the effectiveness of a patient education program developed to facilitate statin adherence

  • When individuals at risk for cardiovascular disease do not adhere to prescribed medical regimens, medication benefits are not fully achieved

  • Half of individuals continue to take prescribed statins at six months, with further declines in adherence at one year [1]. This finding is consistent in individuals who would benefit from primary prevention with statins, as well as in those who have experienced a cardiovascular event; it is especially prominent in asymptomatic individuals, where such treatment is preventive [6,7,8]

Read more

Summary

Introduction

The purpose of this study was to evaluate the effectiveness of a patient education program developed to facilitate statin adherence. Effective management of lipid levels as risk factors for cardiovascular disease requires long-term adherence to a lipid lowering treatment regimen. When individuals at risk for cardiovascular disease do not adhere to prescribed medical regimens, medication benefits are not fully achieved. Half of individuals continue to take prescribed statins at six months, with further declines in adherence at one year [1]. This finding is consistent in individuals who would benefit from primary prevention with statins, as well as in those who have experienced a cardiovascular event; it is especially prominent in asymptomatic individuals, where such treatment is preventive [6,7,8]. Providers may not be using the most effective communication strategies when they do ask about medication-taking behavior [9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call